-
1 Comment
Asian Healthcare Specialists Limited is currently in a long term downtrend where the price is trading 8.4% below its 200 day moving average.
From a valuation standpoint, the stock is 49.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
Asian Healthcare Specialists Limited's total revenue rose by 63.6% to $10M since the same quarter in the previous year.
Its net income has increased by 5.2% to $2M since the same quarter in the previous year.
Finally, its free cash flow fell by 45.0% to $1M since the same quarter in the previous year.
Based on the above factors, Asian Healthcare Specialists Limited gets an overall score of 3/5.
Exchange | SG |
---|---|
CurrencyCode | SGD |
ISIN | None |
Sector | Healthcare |
Industry | Medical Care Facilities |
Target Price | 0.33 |
---|---|
Market Cap | 108M |
PE Ratio | 18.6 |
Beta | 0.24 |
Dividend Yield | 3.8% |
Asian Healthcare Specialists Limited, together with its subsidiaries, provides medical consultancy and services in the field of orthopedic medicine. It operates through Orthopaedic, Anaesthesia, ENT, and Other Medical Services segments. The company offers a range of general and specialized healthcare services, including anesthesia, dermatology, family medicine, gastroenterology, orthopedics, ophthalmology, otorhinolaryngology, urology, and rehabilitative services. It has 13 medical specialists, 1 family physician, and 1 physiotherapist; and 12 clinics in Singapore. Asian Healthcare Specialists Limited was founded in 2013 and is based in Singapore. As of December 15, 2022, Asian Healthcare Specialists Limited operates as a subsidiary of Doctor Anywhere Pte Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1J3.SG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025